Menu
+
+
+
+
+
+
A bipartisan bill introduced Tuesday by members of the Senate Finance Committee would prevent drugmakers from profiting by misclassifying drugs to Medicare as generics.
The bill is in response to a lawsuit against Mylan N.V. (NASDAQ:MYL) for misclassifying its...
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
